[Myelopid correction of disorders in marker characteristics of surface membrane and cytoplasm of neutrophil granulocytes in children with pyoseptic diseases].
Nesterova
I V
IV
Tarakanov
V A
VA
Luniaka
A N
AN
D028341:Activins; D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D015415:Biomarkers / Q000097:blood; D002462:Cell Membrane / Q000187:drug effects; D003593:Cytoplasm / Q000187:drug effects; D006801:Humans; D007223:Infant; D007239:Infections / Q000276:immunology*; D009504:Neutrophils / Q000187:drug effects*; D009842:Oligopeptides; D010455:Peptides / Q000494:pharmacology*; D013492:Suppuration / Q000276:immunology
D000276:Adjuvants, Immunologic; D015415:Biomarkers; D009842:Oligopeptides; D010455:Peptides; C044147:activin B; D028341:Activins; C048617:myelopeptides
Korrektsiia mielopidom narusheniĭ markernoĭ kharakteristiki poverkhnostnoĭ membrany i tsitoplazmy neĭtrofilnykh granulotsitov pri gnoĭno-septicheskikh zabolevaniiakh u deteĭ.